Position | Company | Period |
---|---|---|
Non-Executive Independent Chairman of the Board | Avadel Pharmaceuticals PLC | 1. Juli 2014 - 9. Mai 2019 |
Independent Director | Abercrombie & Fitch Co | 27. Januar 2014 - 1. Juni 2017 |
Independent Director | Avadel Pharmaceuticals PLC | 24. Juni 2011 - 1. Juli 2014 |
Lead Independent Director | Abercrombie & Fitch Co | 23. Februar 2010 - 27. Januar 2014 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2017-09-14 | 2017-09-12 |
Avadel Pharmaceuticals PLC
(AVDL)
|
K Kauf |
20.000
+22.2%
9,52190.360 USD |
20.000 +22.2% | 9,52 | 190.360 USD | |
2016-11-30 | 2016-11-29 |
Avadel Pharmaceuticals PLC
(AVDL)
|
K Kauf |
10.000
+33.3%
10,85108.500 USD |
10.000 +33.3% | 10,85 | 108.500 USD | |
2016-09-06 | 2016-09-01 |
Avadel Pharmaceuticals PLC
(AVDL)
|
K Kauf |
10.000
+2.0%
13,52135.190 USD |
10.000 +2.0% | 13,52 | 135.190 USD | |
2016-08-29 | 2016-08-26 |
Avadel Pharmaceuticals PLC
(AVDL)
|
K Kauf |
9.122
+83.9%
13,67124.698 USD |
9.122 +83.9% | 13,67 | 124.698 USD | |
2016-08-29 | 2016-08-26 |
Avadel Pharmaceuticals PLC
(AVDL)
|
K Kauf |
10.878
+inf%
13,83150.443 USD |
10.878 +inf% | 13,83 | 150.443 USD | |
2016-03-16 | 2016-03-14 |
Avadel Pharmaceuticals PLC
(AVDL)
|
K Kauf |
100.000
+26.1%
10,391.039.400 USD |
100.000 +26.1% | 10,39 | 1.039.400 USD |